?? Unlock advanced insights in glycan analysis with our on-demand webinar! Brian Wei, Senior Scientist at Sanofi, explores new strategies to accommodate increasing analytical demands for process analytical labs. Learn about: ?? CE-based high-throughput method for monitoring the glycan profile of biologics ?? Developing a reproducible method for released N-Glycan analysis What are you waiting for? Tune in now ?? https://sciex.li/87lrex #GlycanAnalysis #ProteinTherapeutics #Biopharma #Biologics #CapillaryElectrophoresis #BioPhase8800
SCIEX Biopharma & Pharma Solutions
生物技术研究
Framingham,Massachusetts 6,566 位关注者
Complete analytical strategies to address the complexities of developing modern therapeutics, from discovery to delivery
关于我们
To bring safe and effective therapies to market, it is vital for pharma and biopharma research to have the right information available at every stage of the process. Transform your analytical workflows by collaborating with a team that is devoted to advancing pharma and biopharma research through a commitment to innovation combined with best-in-class hardware, software and support. Together, we are driving progress for modern medicine and enabling comprehensive small and large molecule analysis, from discovery to commercialization. Follow us now to learn more!
- 网站
-
https://sciex.li/1jg90e
SCIEX Biopharma & Pharma Solutions的外部链接
- 所属行业
- 生物技术研究
- 规模
- 501-1,000 人
- 总部
- Framingham,Massachusetts
动态
-
SCIEX Biopharma & Pharma Solutions转发了
Head – Sales Development (India and High Growth Market) and Sales Manager – West, North, East India Regions
Exciting opportunity to Join SCIEX Biopharma Team.. Check out this job at SCIEX: Sales Development Manager - Biopharma(Hyderabad or Bangalore)
-
As the demand for cell and gene therapies (CGT) continues to grow, ensuring the success of your plasmid manufacturing is more critical than ever. In our latest blog post, we sat down with Dr. Emma Bjorgum, Vice President of Client Services of the DNA Business Unit at Aldevron, to explore the strategies and best practices for setting up robust CGT programs to meet the challenges of today’s fast-evolving biopharma landscape. ?? Optimize plasmid production for high yield and quality ?? Ensure scalability from research to commercial production ?? Implement best practices for regulatory compliance and process control Read the full blog post now ?? https://sciex.li/pg10ro #PlasmidManufacturing #CellandGeneTherapy #Biopharma #PlasmidDNA #AAV #GeneTherapy
-
Glycan analysis is key to improving protein therapeutics, from enhancing efficacy to ensuring batch consistency. In this on-demand webinar, Mike McKinnon, Scientist II at Novartis, explores how achieving high-resolution glycan information can ensure the stability, safety and efficacy of your product. You will learn about: ??New strategies for glycan site localization on a tri-specific antibody ??Benefits of electron activated dissociation (EAD) for glycan profile determination ??Streamline glycan characterization throughout the drug development pipeline with novel methods Don't miss out—watch now and discover how glycan analysis can take your research to the next level ?? https://sciex.li/bicmid #GlycanAnalysis #Biopharma #TriSpecificAntibody #Biologics #LifeSciences #Webinar #Innovation #PharmaceuticalResearch
-
The combination of SCIEX OS software enhancements for the SCIEX 7500+ system performance tracking and the extractable DJet+ assembly offers increased efficiency for user-initiated management of system uptime. For more information ?? https://sciex.li/19w59l #SCIEX #SCIEX7500Plus #WhenItCounts #MassSpec #LCMSanalysis #MassSpectrometry #NewProduct
-
Nitrosamines aren’t just in pharma; they're impacting cosmetics, food, and packaging too. Get the latest insights in our “Pharma trends and solutions compendium.” Download now ??
Pharma trends & solutions
sciex.com
-
?? ???????????????????? ?????? ???????????? ???? ??????????????????: ?????? ?????????????????? ??????'?? ???????????? ???? ????????????????????, ???????????? ????????????, ?????? ???????????????? ???? The BIOSECURE Act promises to reshape the biopharmaceutical landscape, ushering in stricter regulations, enhanced product security, and new compliance demands. This comprehensive article explores insights from industry leaders on what this legislation means for biomanufacturing, innovation, and global partnerships. ?? ?????? ?????????????????? ??????????????: -Enhanced traceability through technologies like blockchain and AI. -A shift in supply chains, reducing dependency on specific regions like China. -Challenges for smaller biotech firms in balancing compliance costs and innovation. -Emerging opportunities for U.S. and global providers to lead in secure, compliant biomanufacturing. -A move toward automation and digitalization to streamline operations and meet new standards. As the biopharma sector adapts to these transformative changes, the BIOSECURE Act could enhance national security, drive competitive innovation, and strengthen public trust. ?? Dive deeper into the article and learn how industry experts view this pivotal moment: https://bit.ly/4eh8wDV #Biopharma #BIOSECUREAct #Innovation #BiotechLeadership #GlobalHealth
-
??Charge variant analysis and how the use of advanced technologies, such as imaged capillary isoelectric focusing (icIEF-UV/MS), can play a key role in biopharmaceutical development. ?? Read this article to learn about the importance of intact-Level PTM identification and charge variant analysis in the #biopharmaceutical industry ?? https://bit.ly/3NLYuQt Technology Networks #TeamSCIEX #Biopharma #ProteinTherapeutics #IntabioZT
-
Only 4 days left! Don't miss our upcoming webinar, where we will explore antibody-drug complexes (ADCs) and the techniques used for their characterization. Check out this short video featuring Lim Sung Taek, Market Development Manager at SCIEX, to discover what you can learn during the webinar. Sign up now ?? https://sciex.li/j81d05 #SCIEX #Webinar #Biopharma #Pharma #ADCCharacterization
-
Kean Woodmansey, Senior Global Market Development Manager here on #TeamSCIEX, gives his take on the anticipated impacts of the #BIOSECURE Act?? https://bit.ly/4eh8wDV